bsri.myeloma.org
The IMF and the Euroflow Consortium Introduce Breakthrough in Detection of Minimal Residual Disease (MRD)
North Hollywood, CA, March 18, 2014 – The International Myeloma Foundation (IMF), in collaboration with the Europe-based EuroFlow consortium, will introduce a new automated and highly sensitive flo…